Sign in

CIK 0000744218

  • Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133191702
Phone
+1 908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 73 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2007-05-24 SEARS PETER A Director Grant or award · Non-Qualified Stock Option +15,000 $0.96 $14K 105,000
2007-05-24 PENNER HARRY JR Director Grant or award · Non-Qualified Stock Option +10,000 $0.96 $10K 95,000
2007-01-05 FREEMAN PAULA R Sr.Dir.Human Resources Grant or award · Incentive Stock Option +15,000 $1.36 $20K 136,550
2007-01-05 RYAN UNA S President & CEO Grant or award · Incentive Stock Option +50,000 $1.36 $68K 1,060,000
2005-05-26 PDI INC Director Grant or award · Non-Qualified Stock Option +10,000 $1.45 $15K 40,000
2004-05-20 PDI INC Director Grant or award · Non-Qualified Stock Options +10,000 $2.68 $27K 30,000
2003-09-18 PDI INC Director Grant or award · Non-Qualified Stock Option +10,000 $2.76 $28K 20,000
2003-09-18 PDI INC Director Grant or award · Non-Qualified Stock Option +10,000 $2.76 $28K 20,000
2003-08-11 PDI INC Director Grant or award · Non-Qualified Stock Option +10,000 $2.10 $21K 10,000

Page 32 of 32 · 629 trades